Cargando…
Repositioning antipsychotic chlorpromazine for treating colorectal cancer by inhibiting sirtuin 1
Investigating existing drugs for repositioning can enable overcoming bottlenecks in the drug development process. Here, we investigated the effect and molecular mechanism of the antipsychotic drug chlorpromazine (CPZ) and identified its potential for treating colorectal cancer (CRC). Human CRC cell...
Autores principales: | Lee, Wen-Ying, Lee, Wai-Theng, Cheng, Chia-Hsiung, Chen, Ku-Chung, Chou, Chih-Ming, Chung, Chu-Hung, Sun, Min-Siou, Cheng, Hung-Wei, Ho, Meng-Ni, Lin, Cheng-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695010/ https://www.ncbi.nlm.nih.gov/pubmed/26363315 |
Ejemplares similares
-
Chlorpromazine as a Potential Antipsychotic Choice in COVID-19 Treatment
por: Muric, Nemanja N., et al.
Publicado: (2020) -
Could the antipsychotic chlorpromazine be a potential treatment for SARS-CoV-2?
por: Nobile, B., et al.
Publicado: (2020) -
Metastatic Colorectal Cancer Rewrites Metabolic Program Through a Glut3-YAP-dependent Signaling Circuit
por: Kuo, Chih-Chia, et al.
Publicado: (2019) -
Repositioning chlorpromazine for treating chemoresistant glioma through the inhibition of cytochrome c oxidase bearing the COX4-1 regulatory subunit
por: Oliva, Claudia R., et al.
Publicado: (2017) -
Repositioning of the antipsychotic drug TFP for sepsis treatment
por: Park, Jung Hwa, et al.
Publicado: (2019)